|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41,700.00 VND | -0.24% |
|
-0.24% | -20.57% |
| 07-01 | Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026 | CI |
| 06-30 | Imexpharm Corporation Announces Management Appointments | CI |
Quotes 5-day view: Imexpharm Corporation
End-of-day quote Ho Chi Minh S.E.| 2026-07-02 | 2026-07-03 | 2026-07-06 | 2026-07-07 | 2026-07-08 | |
|---|---|---|---|---|---|
| Last | ₫42,700.00 | ₫42,950.00 | ₫42,900.00 | ₫41,800.00 | ₫41,700.00 |
| Volume | 5,482 | 13,451 | 15,834 | 6,102 | 1,204 |
| Change | +2.15% | +0.59% | -0.12% | -2.56% | -0.24% |
| Opening | ₫42,900.00 | ₫42,950.00 | ₫43,050.00 | ₫42,900.00 | ₫41,500.00 |
| High | ₫42,950.00 | ₫43,150.00 | ₫43,100.00 | ₫42,900.00 | ₫41,950.00 |
| Low | ₫41,950.00 | ₫42,850.00 | ₫41,500.00 | ₫41,700.00 | ₫41,500.00 |
Performance
| 1 day | -0.24% | ||
| 1 week | -0.24% | ||
| Current month | +1.21% | ||
| 1 month | -8.95% | ||
| 3 months | -25.00% | ||
| 6 months | -20.57% | ||
| Current year | -20.57% | ||
| 1 year | -20.11% | ||
| 3 years | +50.75% | ||
| 5 years | +28.78% | ||
| 10 years | +207.59% |
Volumes
marketsDaily volume
1,204
Avg. Volume 20 sessions
12,236
Avg. Volume 20 sessions VND
510,241,200
Avg. Volume 20 sessions USD
19,389.17
Record volume 1
26,307,988
Record volume 2
12,247,012
Record volume 3
11,403,140
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (VND)
6,437,574,613,170
Market Cap (USD)
244,830,555
Net sales (VND)
2,441,085,482,090
Net sales (USD)
92,838,118
Number of employees
1,444
Sales / Employee (VND)
1,690,502,411
Sales / Employee (USD)
64,292
Free-Float
6.42 %
Free-Float capitalization (VND)
413,697,776,901
Free-Float capitalization (USD)
15,733,543
Average Daily Capital Traded
0.01%
Indicators
Moving average 5 days
42,410
Moving average 20 days
43,715
Moving average 50 days
45,715
Moving average 100 days
50,176
Price spread / (MMA5)
+1.70%
Price spread / (MMA20)
+4.83%
Price spread / (MMA50)
+9.63%
Price spread / (MMA100)
+20.33%
RSI 9 days
29.61
RSI 14 days
29.15
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.24% | -0.24% | -20.11% | +50.75% | 245M | |
| -1.60% | +2.02% | +56.34% | +168.94% | 1,102B | |
| -1.44% | +3.71% | +69.07% | +65.40% | 643B | |
| -0.75% | +0.67% | +33.18% | +86.52% | 450B | |
| -1.35% | +1.86% | +29.96% | +26.28% | 336B | |
| -0.86% | +2.79% | +37.72% | +40.85% | 298B | |
| -0.71% | +0.72% | +28.85% | +48.27% | 288B | |
| -1.31% | -0.26% | -28.18% | -39.82% | 222B | |
| -0.03% | +1.84% | +23.90% | +68.30% | 199B | |
| -0.40% | +7.82% | +22.29% | +82.50% | 169B | |
| Average | -0.87% | +2.43% | +25.30% | +59.80% | 370.62B | |
| Weighted average by Cap. | -1.16% | +2.71% | +41.37% | +86.54% |
Historical Quotes: Imexpharm Corporation
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 41,500 |  | 43,150 |
| 1 month | 41,100 | | 46,300 |
| Current year | 41,100 | | 57,000 |
| 1 year | 41,100 | | 57,000 |
| 3 years | 23,681.82 | | 57,000 |
| 5 years | 18,831.17 | | 57,000 |
| 10 years | 12,503.97 | | 57,000 |
Monthly variations
Annual variations
| 2026 | -20.57% | ||
| 2025 | +11.70% | ||
| 2024 | +82.69% | ||
| 2023 | -1.28% | ||
| 2022 | -22.62% | ||
| 2021 | +38.19% | ||
| 2020 | +52.48% | ||
| 2019 | -21.18% | ||
| 2018 | +6.11% | ||
| 2017 | +29.87% | ||
| 2016 | +49.07% | ||
| 2015 | -10.29% | ||
| 2014 | +68.10% | ||
| 2013 | +5.67% | ||
| 2012 | +0.34% | ||
| 2011 | -37.07% | ||
| 2010 | -27.22% | ||
| 2009 | +12.67% | ||
| 2008 | -59.89% | ||
| 2007 | +41.67% |
- Stock Market
- Stocks
- IMP Stock
- Quotes Imexpharm Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
